Jazz Pharmaceuticals, Inc. (JAZZ) Tops Q1 EPS by 7c
Tweet
Share
E-mailGet Alerts JAZZ Hot Sheet
Price: $248.95 +0.39%
Financial Fact:
Selling, general and administrative: 124.37M
Today's EPS Names:
PLNH, SPRU, BBGI, More
Financial Fact:
Selling, general and administrative: 124.37M
Today's EPS Names:
PLNH, SPRU, BBGI, More
Join SI Premium – FREE
Jazz Pharmaceuticals, Inc. (NASDAQ: JAZZ) reported Q1 EPS of $0.91, $0.07 better than the analyst estimate of $0.84.
For earnings history and earnings-related data on Jazz Pharmaceuticals, Inc. (JAZZ) click here.
For earnings history and earnings-related data on Jazz Pharmaceuticals, Inc. (JAZZ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CAE, Inc. (CAE) Tops Q1 EPS by 2c, Beats on Revenue; Offers FY27 EPS Guidance
- SeaStar Medical (ICU) Misses Q1 EPS by 4c
- Spire Global (SPIR) Tops Q2 EPS by 2c; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
